dalteparin has been researched along with Neuralgia, Sciatic in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hodzic-Avdagic, N | 1 |
| Sonntag, M | 1 |
| Burchardt, T | 1 |
| Megahed, M | 1 |
| Olmarker, K | 1 |
| Rydevik, B | 1 |
2 other studies available for dalteparin and Neuralgia, Sciatic
| Article | Year |
|---|---|
[Congelatio bullosa after inappropriate use of refrigeration unit].
Topics: Aged; Anti-Infective Agents; Anticoagulants; Ciprofloxacin; Cryotherapy; Enoxaparin; Female; Fibrino | 2003 |
Selective inhibition of tumor necrosis factor-alpha prevents nucleus pulposus-induced thrombus formation, intraneural edema, and reduction of nerve conduction velocity: possible implications for future pharmacologic treatment strategies of sciatica.
Topics: Animals; Antibodies, Monoclonal; Anticoagulants; Antirheumatic Agents; Cauda Equina; Edema; Enoxapar | 2001 |